Veterinary Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type [Livestock Vaccines (Bovine Vaccines and Small Ruminant Vaccines) and Companion Animal Vaccines (Feline Vaccines, Canine Vaccines, and Others)] and Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, and Others)
Veterinary Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type [Livestock Vaccines (Bovine Vaccines and Small Ruminant Vaccines) and Companion Animal Vaccines (Feline Vaccines, Canine Vaccines, and Others)] and Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, and Others)
Beyond The Burden: The Impact of Atrial Fibrillation in the Asia Pacific by Biosense Webster, published in 2019, more than 16 million people in Asia Pacific suffer from atrial fibrillation, and the number is expected to reach ~72 million by 2050. The report also suggests that the middle-aged and elderly population is at a greater risk of developing this condition.
Most types of CVDs can be prevented through pre-monitoring and pre-diagnosis. Likewise, arrhythmias, i.e., abnormalities in the heart functioning, can be averted with early diagnosis. The demand for arrhythmia monitoring devices is increasing as these devices can help save patients at a high risk of cardiac arrest. This results in the healthcare industry adopting new and innovative devices to ensure enhanced medical care and investing in better healthcare facilities, in turn, boosting demand for monitoring devices such as Holter ECG monitors. To avoid risks associated with CVDs, Holter ECG are widely used by population who are likely to be exposed to factors that cause CVD. Holter ECG monitor records the heart's activity (ECG) continuously for 24–48 hours, essential for safe diagnosis and therapy control, which is a major factor fueling its demand.
Component Insights
Based on components, the global Holter ECG market is segmented into wired Holter monitors, wireless Holter monitors, and Holter analysis systems and software. In 2020, the wired Holter monitors segment held the largest share of the market. However, the wireless Holter monitors segment is expected to register the highest CAGR in the market during 2021–2028. With the help of wireless Holter monitors, individuals can easily move around independently. Therefore, the adaption of these devices is increasing, which is expected to drive the market during the forecast period.
End-user Insights
Based on end-users, the Holter ECG market is segmented into hospitals and clinics, ambulatory surgical centers, home settings, and others. The hospital and clinics segment held the largest market share in 2021. However, the home settings segment is expected to hold a significant market share in the market during the forecast period. Holter ECG is simple to operate, does not require additional medical training, and increases the patient's comfort by telemonitoring at home due to mobility of the device, which allows patients to function normally in daily routine. These factors are expected to propel its demand in home settings in the future.
A few major primary and secondary sources referred to while preparing the report on the global Holter ECG market are the World Health Organization, Center for Disease Control and Prevention, European Union, American Heart Association, Italian National Health Service, National Center for Biotechnology Information, China National Committee on Aging, Institute for Health Metrics and Evaluation, U.S. Food and Drug Administration. Reason to buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Veterinary Vaccines market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global Veterinary Vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distributionReason to buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Veterinary Vaccines market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global Veterinary Vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
The List of Companies - Veterinary Vaccines Market
1. Boehringer Ingelheim International GmbH2. MERCK3. Zoetis Services LLC4. Elanco5. Vetoquinol6. Ceva7. Virbac8. NEOGEN Corporation9. Biovac10. ImmuCell Corporation
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook